Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

High risk clinic: follow-up of healthy individuals with genetic predisposition to breast cancer

Share :

MBCC 12

16 - 18 Jun 2010
Published: 2 Sep 2010
Views: 7275
Rating:
Save
Dr Bernardo Bonanni - European Institute of Oncology, Milan, Italy

Dr Bernardo Bonanni - European Institute of Oncology, Milan, Italy, speaking at the 12th Milan Breast Cancer Conference, June 2010. High risk clinic: follow-up of healthy individuals with genetic predisposition to breast cancer. Download the slides here.

Related Videos

Tackling breast cancer screening in conservative communities
Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America
Tackling breast cancer screening in conservative communities ( Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America )
24 Oct 2024
Post-diagnosis diet, nutrition and cancer prognosis
Dr Doris Chan - Imperial College London, London, UK
Post-diagnosis diet, nutrition and cancer prognosis ( Dr Doris Chan - Imperial College London, London, UK )
24 Oct 2024
WCI's role in the prevention of tobacco related cancer among Beedi rolling...
Dr Surendran Veeraiah - Cancer Institute (WIA) Adyar, Chennai, India
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India ( Dr Surendran Veeraiah - Cancer Institute (WIA) Adyar, Chennai, India )
23 Oct 2024
Alternative livelihood training programme for rural women who are employed in...
Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India ( Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India )
23 Oct 2024
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...
Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Trastuzumab deruxtecan effective against brain metastases in HER2-positive...
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Genomic testing: Awareness and effective communication between healthcare...
Prof Richard Simcock and Antonella Cardone
Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )
22 Oct 2023
Advancing breast cancer treatment in Uganda by improving molecular testing
Dr Jackson Orem - Uganda Cancer Institute, Kampala, Uganda
Advancing breast cancer treatment in Uganda by improving molecular testing ( Dr Jackson Orem - Uganda Cancer Institute, Kampala, Uganda )
8 Jun 2023
Somatic mutation profile of breast cancer in Uganda
Dr Manoj Menon - Fred Hutchinson Cancer Center, Seattle, USA
Somatic mutation profile of breast cancer in Uganda ( Dr Manoj Menon - Fred Hutchinson Cancer Center, Seattle, USA )
8 Jun 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation